The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals / edited by Ursula Grohmann and Paolo Puccetti.
Indoleamine 2,3-dioxygenase (IDO1) is an ancestral enzyme that, initially confined to the regulation of tryptophan availability in local tissue microenvironments, is now considered to play a wider role that extends to homeostasis and plasticity of the immune system. Thus IDO biology has implications...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Lausanne, Switzerland : : Frontiers Media SA,, 2016. ©2016 |
Year of Publication: | 2016 |
Language: | English |
Series: | Frontiers research topics
|
Physical Description: | 1 online resource (89 pages) :; illustrations, charts; digital, PDF file(s). |
Notes: | Published in Frontiers in Immunology. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993547697504498 |
---|---|
ctrlnum |
(CKB)3710000000631114 (oapen)https://directory.doabooks.org/handle/20.500.12854/43454 (EXLCZ)993710000000631114 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ursula Grohmann auth The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals [electronic resource] / edited by Ursula Grohmann and Paolo Puccetti. Frontiers Media SA 2016 Lausanne, Switzerland : Frontiers Media SA, 2016. ©2016 1 online resource (89 pages) : illustrations, charts; digital, PDF file(s). text txt rdacontent computer c rdamedia online resource cr rdacarrier text file rda Frontiers research topics Published in Frontiers in Immunology. Indoleamine 2,3-dioxygenase (IDO1) is an ancestral enzyme that, initially confined to the regulation of tryptophan availability in local tissue microenvironments, is now considered to play a wider role that extends to homeostasis and plasticity of the immune system. Thus IDO biology has implications for many aspects of immunopathology, including viral infections, neoplasia, autoimmunity, and chronic inflammation. Its immunoregulatory effects are mainly mediated by dendritic cells (DCs) and involve not only tryptophan deprivation but also production of kynurenines that act on IDO− DCs, thus rendering an otherwise stimulatory DC capable of regulatory effects, as well as on T cells. The aryl hydrocarbon receptor (AhR) is a ligand-operated transcription factor originally recognized as the effector mediating the pathologic effects of dioxins and other pollutants. However, it is now well established that AhR activation by endogenous ligands can produce immunoregulatory effects. The IDO1 mechanism appears to have been selected through phylogenesis primarily to prevent overreacting responses to TLR-recognized pathogen-associated molecular patterns, and only later did it become involved in the response to T cell receptor-recognized antigens. As a result, in mammals, IDO1 has become pivotal in fetomaternal tolerance, at a time when regulatory T cells emerged to meet the same need, namely protecting the fetus. IDO1 and regulatory T (Treg) cells may have then coevolved to broaden their function well beyond their initial task of protecting the fetus, such that, in acquired immunity, IDO1 (with its dual enzymic and signaling function) has turned into an important component of the peripheral generation and effector function of regulatory T cells. AhR, in turn, which has a role in regulatory T-cell generation, is presumed to have evolved from invertebrates, where it served a ligand-independent role in normal development processes. Evolution of the receptor in vertebrates resulted in the ability to bind structurally different ligands, including xenobiotics and microbiota-derived catabolites. Considering the inability of invertebrate AhR homologs to bind dioxins, the adaptive role of the AhR to act as a regulator of xenobiotic-metabolizing enzymes may have been a vertebrate innovation, to later acquire an additional immune regulatory role by coevolutive pressure in mammals by IDO1 and regulatory T cells. Thus an entirely new paradigm in immunology, and more specifically in immune tolerance, is the coevolution of three systems, namely, the IDO1 mechanism, AhR-driven gene transcription, and T-cell regulatory activity, that originating from the initial need of protecting the fetus in mammals, have later turned into a pivotal mechanism of peripheral tolerance in autoimmunity, transplantation, and neoplasia. English Immunology. Aryl hydrocarbon receptor (AhR) indoleamine dioxygenase 1 and 2 (IDO1 and IDO2) tryptophan dioxygenase (TDO2) tryptophan metabolism Immune Regulation Grohmann. Ursula, editor. Puccetti, Paolo, editor. 2-88919-729-8 |
language |
English |
format |
Electronic eBook |
author |
Ursula Grohmann |
spellingShingle |
Ursula Grohmann The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals Frontiers research topics |
author_facet |
Ursula Grohmann Grohmann. Ursula, Puccetti, Paolo, |
author_variant |
u g ug |
author2 |
Grohmann. Ursula, Puccetti, Paolo, |
author2_variant |
g u gu p p pp |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Ursula Grohmann |
title |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals |
title_full |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals [electronic resource] / edited by Ursula Grohmann and Paolo Puccetti. |
title_fullStr |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals [electronic resource] / edited by Ursula Grohmann and Paolo Puccetti. |
title_full_unstemmed |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals [electronic resource] / edited by Ursula Grohmann and Paolo Puccetti. |
title_auth |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals |
title_new |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals |
title_sort |
the coevolution of ido1 and ahr in the emergence of regulatory t cells in mammals |
series |
Frontiers research topics |
series2 |
Frontiers research topics |
publisher |
Frontiers Media SA Frontiers Media SA, |
publishDate |
2016 |
physical |
1 online resource (89 pages) : illustrations, charts; digital, PDF file(s). |
isbn |
2-88919-729-8 |
illustrated |
Illustrated |
work_keys_str_mv |
AT ursulagrohmann thecoevolutionofido1andahrintheemergenceofregulatorytcellsinmammals AT grohmannursula thecoevolutionofido1andahrintheemergenceofregulatorytcellsinmammals AT puccettipaolo thecoevolutionofido1andahrintheemergenceofregulatorytcellsinmammals AT ursulagrohmann coevolutionofido1andahrintheemergenceofregulatorytcellsinmammals AT grohmannursula coevolutionofido1andahrintheemergenceofregulatorytcellsinmammals AT puccettipaolo coevolutionofido1andahrintheemergenceofregulatorytcellsinmammals |
status_str |
n |
ids_txt_mv |
(CKB)3710000000631114 (oapen)https://directory.doabooks.org/handle/20.500.12854/43454 (EXLCZ)993710000000631114 |
carrierType_str_mv |
cr |
is_hierarchy_title |
The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796651906781675520 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04327nam a2200421 i 4500</leader><controlfield tag="001">993547697504498</controlfield><controlfield tag="005">20230808192419.0</controlfield><controlfield tag="006">a fs d </controlfield><controlfield tag="007">cr#mn#---|||||</controlfield><controlfield tag="008">160411t20162016sz ad fob u|00 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000631114</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/43454</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000631114</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="d">UkMaJRU</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ursula Grohmann</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="4"><subfield code="a">The coevolution of IDO1 and AHR in the emergence of regulatory T cells in mammals</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">edited by Ursula Grohmann and Paolo Puccetti.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lausanne, Switzerland :</subfield><subfield code="b">Frontiers Media SA,</subfield><subfield code="c">2016.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (89 pages) :</subfield><subfield code="b">illustrations, charts; digital, PDF file(s).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers research topics</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Published in Frontiers in Immunology.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Indoleamine 2,3-dioxygenase (IDO1) is an ancestral enzyme that, initially confined to the regulation of tryptophan availability in local tissue microenvironments, is now considered to play a wider role that extends to homeostasis and plasticity of the immune system. Thus IDO biology has implications for many aspects of immunopathology, including viral infections, neoplasia, autoimmunity, and chronic inflammation. Its immunoregulatory effects are mainly mediated by dendritic cells (DCs) and involve not only tryptophan deprivation but also production of kynurenines that act on IDO− DCs, thus rendering an otherwise stimulatory DC capable of regulatory effects, as well as on T cells. The aryl hydrocarbon receptor (AhR) is a ligand-operated transcription factor originally recognized as the effector mediating the pathologic effects of dioxins and other pollutants. However, it is now well established that AhR activation by endogenous ligands can produce immunoregulatory effects. The IDO1 mechanism appears to have been selected through phylogenesis primarily to prevent overreacting responses to TLR-recognized pathogen-associated molecular patterns, and only later did it become involved in the response to T cell receptor-recognized antigens. As a result, in mammals, IDO1 has become pivotal in fetomaternal tolerance, at a time when regulatory T cells emerged to meet the same need, namely protecting the fetus. IDO1 and regulatory T (Treg) cells may have then coevolved to broaden their function well beyond their initial task of protecting the fetus, such that, in acquired immunity, IDO1 (with its dual enzymic and signaling function) has turned into an important component of the peripheral generation and effector function of regulatory T cells. AhR, in turn, which has a role in regulatory T-cell generation, is presumed to have evolved from invertebrates, where it served a ligand-independent role in normal development processes. Evolution of the receptor in vertebrates resulted in the ability to bind structurally different ligands, including xenobiotics and microbiota-derived catabolites. Considering the inability of invertebrate AhR homologs to bind dioxins, the adaptive role of the AhR to act as a regulator of xenobiotic-metabolizing enzymes may have been a vertebrate innovation, to later acquire an additional immune regulatory role by coevolutive pressure in mammals by IDO1 and regulatory T cells. Thus an entirely new paradigm in immunology, and more specifically in immune tolerance, is the coevolution of three systems, namely, the IDO1 mechanism, AhR-driven gene transcription, and T-cell regulatory activity, that originating from the initial need of protecting the fetus in mammals, have later turned into a pivotal mechanism of peripheral tolerance in autoimmunity, transplantation, and neoplasia.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Immunology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Aryl hydrocarbon receptor (AhR)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">indoleamine dioxygenase 1 and 2 (IDO1 and IDO2)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tryptophan dioxygenase (TDO2)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tryptophan metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immune Regulation</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grohmann. Ursula,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Puccetti, Paolo,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-729-8</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-10 02:20:15 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2016-04-12 04:07:06 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338591780004498&Force_direct=true</subfield><subfield code="Z">5338591780004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338591780004498</subfield></datafield></record></collection> |